Hanson John M 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Oct 1, 2009
Insider Transaction Report
Form 4
Hanson John M
Executive VP & CFO
Transactions
- Award
Option (right to buy)
2009-09-30+35,266→ 35,266 totalExercise: $19.00Exp: 2019-09-30→ Common Stock (35,266 underlying) - Award
Common Stock
2009-09-30+17,763→ 99,619 total
Footnotes (3)
- [F1]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of restricted share units representing the right to receive 17,763 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
- [F2]The number of shares reported includes 33,920 shares that have not yet vested of the Issuer's common stock that were granted by the Issuer to the Reporting Person on December 6, 2006 and which will vest on March 31, 2010, subject to the Reporting Person's continuous service with the Issuer through that date, as detailed in a restricted stock award agreement by and between the Issuer and the Reporting Person, dated as of December 6, 2006.
- [F3]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of options to purchase the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.